<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04274777</url>
  </required_header>
  <id_info>
    <org_study_id>TDSJWKTBIC</org_study_id>
    <nct_id>NCT04274777</nct_id>
  </id_info>
  <brief_title>The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders</brief_title>
  <official_title>The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tang-Du Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to observe the relationship between the level of lipid
      peroxidation products in serum of patients with traumatic brain injury and secondary
      coagulation disorders.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Uncontrolled hemorrhage after trauma is the leading cause of death. The mechanism of
      secondary coagulation dysfunction after trauma is special and complex, which has not been
      fully explained, leading to limited treatment and prevention methods. Coagulation disorders
      caused by traumatic brain injury is a systemic manifestation of local injury, which can
      activate platelets and promote platelet aggregation, activate thrombin, and promote the
      production of fibrin, leading to the formation of thrombosis. However, in non-injured areas,
      pro-coagulant molecules from damaged brain tissue reach the body through the broken
      blood-brain barrier, and also activate platelets and thrombin, promoting the formation of
      blood clots. Lipid peroxidation products are closely related to the occurrence of coagulation
      dysfunction. The effects lipid peroxidation products on platelets, thrombin and anticoagulant
      pathways may be a novel mechanism of secondary coagulation dysfunction in traumatic brain
      injury.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2019</start_date>
  <completion_date type="Anticipated">December 21, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 21, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The level of lipid peroxidation products in subjects' serum</measure>
    <time_frame>within 24 hours of trauma</time_frame>
    <description>the level of high and low</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Coagulation Disorders</measure>
    <time_frame>within 24 hours of trauma</time_frame>
    <description>aPTT&gt;40s or INR&gt;1.4 or &lt;100 platelets per L</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The 24-hour and 3-month Glasgow outcome score (GOS)</measure>
    <time_frame>from onset to three months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <condition>Coagulation Disorder</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All of the traumatic brain injury patients receiving treatment in Tangdu Hospital during
        2019-2020
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The interval between injury and admission is less than 24 hours

          2. Age&gt;18yrs and age&lt;80yrs

          3. Non-head abbreviated injury score &lt; 3

          4. Did not undertake treatment before enrollment

          5. Informed consent to participate in the study

        Exclusion Criteria:

          1. Take anticoagulants or antiplatelet drugs

          2. Smoking history

          3. Hemorrhagic or ischemic cerebrovascular disease occurred within six months

          4. Other systemic diseases: uremia, cirrhosis, malignant tumor, etc

          5. Patients with severe mental illness who are unable to communicate when diagnosed

          6. Patients who refused follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan Qu, M.D, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Tang-Du Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shunnan Ge, M.D, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Tang-Du Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wenxing Cui, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tang-Du Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wenxing Cui, M.D</last_name>
    <phone>86-17367277315</phone>
    <email>wenxingcui@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tandu Hospital, Fourth Military Medical University</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenxing Cui, M.D</last_name>
      <phone>86-17367277315</phone>
      <email>wenxingcui@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Harhangi BS, Kompanje EJ, Leebeek FW, Maas AI. Coagulation disorders after traumatic brain injury. Acta Neurochir (Wien). 2008 Feb;150(2):165-75; discussion 175. doi: 10.1007/s00701-007-1475-8. Epub 2008 Jan 2. Review.</citation>
    <PMID>18166989</PMID>
  </reference>
  <reference>
    <citation>Epstein DS, Mitra B, O'Reilly G, Rosenfeld JV, Cameron PA. Acute traumatic coagulopathy in the setting of isolated traumatic brain injury: a systematic review and meta-analysis. Injury. 2014 May;45(5):819-24. doi: 10.1016/j.injury.2014.01.011. Epub 2014 Jan 19. Review.</citation>
    <PMID>24529718</PMID>
  </reference>
  <reference>
    <citation>Zehtabchi S, Soghoian S, Liu Y, Carmody K, Shah L, Whittaker B, Sinert R. The association of coagulopathy and traumatic brain injury in patients with isolated head injury. Resuscitation. 2008 Jan;76(1):52-6. Epub 2007 Aug 15.</citation>
    <PMID>17706857</PMID>
  </reference>
  <reference>
    <citation>Maeda T, Katayama Y, Kawamata T, Aoyama N, Mori T. Hemodynamic depression and microthrombosis in the peripheral areas of cortical contusion in the rat: role of platelet activating factor. Acta Neurochir Suppl. 1997;70:102-5.</citation>
    <PMID>9416292</PMID>
  </reference>
  <reference>
    <citation>Zhang J, Zhang F, Dong JF. Coagulopathy induced by traumatic brain injury: systemic manifestation of a localized injury. Blood. 2018 May 3;131(18):2001-2006. doi: 10.1182/blood-2017-11-784108. Epub 2018 Mar 5. Review.</citation>
    <PMID>29507078</PMID>
  </reference>
  <reference>
    <citation>Zhao Z, Wang M, Tian Y, Hilton T, Salsbery B, Zhou EZ, Wu X, Thiagarajan P, Boilard E, Li M, Zhang J, Dong JF. Cardiolipin-mediated procoagulant activity of mitochondria contributes to traumatic brain injury-associated coagulopathy in mice. Blood. 2016 Jun 2;127(22):2763-72. doi: 10.1182/blood-2015-12-688838. Epub 2016 Mar 21.</citation>
    <PMID>27002118</PMID>
  </reference>
  <reference>
    <citation>Wu Y, Liu W, Zhou Y, Hilton T, Zhao Z, Liu W, Wang M, Yeon J, Houck K, Thiagarajan P, Zhang F, Shi FD, Wu X, Li M, Dong JF, Zhang J. von Willebrand factor enhances microvesicle-induced vascular leakage and coagulopathy in mice with traumatic brain injury. Blood. 2018 Sep 6;132(10):1075-1084. doi: 10.1182/blood-2018-03-841932. Epub 2018 Jun 25.</citation>
    <PMID>29941674</PMID>
  </reference>
  <reference>
    <citation>Tian Y, Salsbery B, Wang M, Yuan H, Yang J, Zhao Z, Wu X, Zhang Y, Konkle BA, Thiagarajan P, Li M, Zhang J, Dong JF. Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury. Blood. 2015 Mar 26;125(13):2151-9. doi: 10.1182/blood-2014-09-598805. Epub 2015 Jan 27.</citation>
    <PMID>25628471</PMID>
  </reference>
  <reference>
    <citation>Zhou Y, Cai W, Zhao Z, Hilton T, Wang M, Yeon J, Liu W, Zhang F, Shi FD, Wu X, Thiagarajan P, Li M, Zhang J, Dong JF. Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice. Blood. 2018 Feb 1;131(5):563-572. doi: 10.1182/blood-2017-08-801738. Epub 2017 Nov 21.</citation>
    <PMID>29162596</PMID>
  </reference>
  <reference>
    <citation>Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Filipescu D, Hunt BJ, Komadina R, Nardi G, Neugebauer EA, Ozier Y, Riddez L, Schultz A, Vincent JL, Spahn DR. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016 Apr 12;20:100. doi: 10.1186/s13054-016-1265-x.</citation>
    <PMID>27072503</PMID>
  </reference>
  <reference>
    <citation>Hyder AA, Wunderlich CA, Puvanachandra P, Gururaj G, Kobusingye OC. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation. 2007;22(5):341-53. Review.</citation>
    <PMID>18162698</PMID>
  </reference>
  <reference>
    <citation>Sun Y, Wang J, Wu X, Xi C, Gai Y, Liu H, Yuan Q, Wang E, Gao L, Hu J, Zhou L. Validating the incidence of coagulopathy and disseminated intravascular coagulation in patients with traumatic brain injury--analysis of 242 cases. Br J Neurosurg. 2011 Jun;25(3):363-8. doi: 10.3109/02688697.2011.552650. Epub 2011 Feb 28.</citation>
    <PMID>21355766</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 24, 2019</study_first_submitted>
  <study_first_submitted_qc>February 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2020</study_first_posted>
  <last_update_submitted>February 16, 2020</last_update_submitted>
  <last_update_submitted_qc>February 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Traumatic Brain Injury</keyword>
  <keyword>Coagulation Disorder</keyword>
  <keyword>Lipid Peroxidation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

